IL34 and early-onset autosomal dominant Alzheimer disease: The study by Mizuno et al. (30) demonstrated that in vitro, microglia treated with IL-34 attenuated the neurotoxic effects of oligomeric amyloid-β (oAβ), which mediates synaptic dysfunction and neuronal damage in Alzheimer’s disease.